COCP · ISSUER CIK 1412486
Cocrystal Pharma, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Cocrystal Pharma, Inc. insiders reported $80K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Frost Phillip Md Et Al (Director, 10% Owner), with $80K.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$80KInsider buying
$0.00Insider selling
+$80KNet open-market
Aug 6, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 202617:11 | Aug 5, 2026 | COCP | Director, 10% Owner | P · Buy | $0.98 | +10,000 | 1,993,551 | +1% | +$10K | -31.8% | -0.2% |
| Aug 5, 202616:10 | Aug 3, 2026 | COCP | Director, 10% Owner | P · Buy | $0.94 | +75,000 | 1,983,551 | +4% | +$71K | -34.6% | +4.1% |